SLC1A5 and pachyonychia congenita: Although SLC1A5 expression in dasatinib-sensitive PC cells was higher than that in dasatinib-resistant PC cells in the GSE59357 dataset (Figure 6C), SLC1A5 expression was not correlated with the drug sensitivity of dasatinib (Figure 6D).